The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Don’t drop the baton: A multidisciplinary and interprofessional approach to improving transfer of accountability and information transfer (TOAI).
 
Anum Ali
No Relationships to Disclose
 
Victoria Glinsky
No Relationships to Disclose
 
Alyssa Macedo
No Relationships to Disclose
 
Hilary Weatherby
No Relationships to Disclose
 
Rebecca Bagnarol
No Relationships to Disclose
 
Ernie Mak
No Relationships to Disclose
 
Ishan Acharya
Stock and Other Ownership Interests - Moderna Therapeutics
 
Ian Hirsch
No Relationships to Disclose
 
Enrique Sanz Garcia
Research Funding - Novartis Canada Pharmaceuticals Inc
 
Ana Luisa Costa
No Relationships to Disclose
 
Claudia Grande
No Relationships to Disclose
 
Pearlina Dawes
No Relationships to Disclose
 
Ezra Hahn
No Relationships to Disclose
 
Eugene Leung
No Relationships to Disclose
 
Santhosh Thyagu
No Relationships to Disclose
 
Vikas Gupta
Stock and Other Ownership Interests - Syndax
Honoraria - Abbvie; Bristol-Myers Squibb/Celgene; CTI biophara; GlaxoSmithKline; Incyte; Novartis; Pfizer
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; CTI BioPharma Corp; GlaxoSmithKline; Incyte; Novartis
Research Funding - Abbvie (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent on MPN24 a gene signature to predict outcome of Myelofibrosis (Inst)
 
Auro Viswabandya
No Relationships to Disclose
 
Anet Julius
No Relationships to Disclose
 
Monika K. Krzyzanowska
Consulting or Advisory Role - Bayer; Eisai; Lilly; Novartis
Research Funding - Exelixis (Inst); Lilly (Inst); Novartis (Inst)
 
Neesha C. Dhani
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Knight Therapeutics; Merck